Adlai R. Grayson

831 total citations
7 papers, 612 citations indexed

About

Adlai R. Grayson is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Adlai R. Grayson has authored 7 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Hematology. Recurrent topics in Adlai R. Grayson's work include Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Adlai R. Grayson is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Adlai R. Grayson collaborates with scholars based in United States, United Kingdom and Malaysia. Adlai R. Grayson's co-authors include Christopher A. French, Erica M. Walsh, Mitzi I. Kuroda, Peter Hsi, Peter V. Kharchenko, Artyom A. Alekseyenko, Xin Wang, Peter M. Howley, Madeleine E. Lemieux and Paola Dal Cin and has published in prestigious journals such as Genes & Development, Advanced Drug Delivery Reviews and Oncogene.

In The Last Decade

Adlai R. Grayson

7 papers receiving 600 citations

Peers

Countries citing papers authored by Adlai R. Grayson

Since Specialization

Citations

This map shows the geographic impact of Adlai R. Grayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adlai R. Grayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adlai R. Grayson more than expected).

Fields of papers citing papers by Adlai R. Grayson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adlai R. Grayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adlai R. Grayson. The network helps show where Adlai R. Grayson may publish in the future.

Co-authorship network of co-authors of Adlai R. Grayson

This figure shows the co-authorship network connecting the top 25 collaborators of Adlai R. Grayson. A scholar is included among the top collaborators of Adlai R. Grayson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adlai R. Grayson. Adlai R. Grayson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	LGBTQ+ Equity in Virtual Residency Recruitment: Innovations and Recommendations 2021 ·Journal of Graduate Medical Education ·(unknown), Adlai R. Grayson, (unknown), (unknown)	7
2	Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor 2020 ·Molecular Cancer Therapeutics ·Remi Adelaiye‐Ogala, Berkley E. Gryder, Yen Thi Minh Nguyen, Aian Neil Alilin, Adlai R. Grayson, (unknown), Keith H. Jansson, Michael L. Beshiri, Supreet Agarwal, (unknown), Brian J. Capaldo, Kathleen Kelly, David James VanderWeele	34
3	Palm Fruit Bioactives modulate human astrocyte activity in vitro altering the cytokine secretome reducing levels of TNFα, RANTES and IP-10 2018 ·Scientific Reports ·(unknown), (unknown), Kirsten Schneider, T. G. Sambandan, Adlai R. Grayson, (unknown), (unknown), Ravigadevi Sambanthamurthi, (unknown), Anthony J. Sinskey, ChoKyun Rha	22
4	The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2015 ·Genes & Development ·Artyom A. Alekseyenko, Erica M. Walsh, Xin Wang, Adlai R. Grayson, Peter Hsi, Peter V. Kharchenko, Mitzi I. Kuroda, Christopher A. French	135
5	NSD3–NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism 2014 ·Cancer Discovery ·Christopher A. French, Shaila Rahman, Erica M. Walsh, Simone Kühnle, Adlai R. Grayson, Madeleine E. Lemieux, Noam Grunfeld, Brian P. Rubin, Cristina R. Antonescu, Songlin Zhang, Rajkumar Venkatramani, Paola Dal Cin, Peter M. Howley	186
6	MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma 2013 ·Oncogene ·Adlai R. Grayson, Erica M. Walsh, Michael J. Cameron, Jernej Godec, Todd Ashworth, (unknown), Alexandra Aserlind, Hongfang Wang, Gérard I. Evan, Michael Kluk, James E. Bradner, Jon C. Aster, Christopher A. French	142
7	Electronic MEMS for triggered delivery 2003 ·Advanced Drug Delivery Reviews ·Adlai R. Grayson	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact